AI-Powered Ingredient Discovery: A New Frontier for Pet Prebiotics?

Executive Summary

The application of artificial intelligence (AI) to ingredient discovery is gaining momentum in the human food industry and is now beginning to influence the development of functional ingredients for animal nutrition. A notable example is the collaboration between Ingredion, a global ingredient solutions provider, and Shiru, an AI-driven ingredient discovery company, to identify novel prebiotics. While this collaboration was reported primarily in the context of human food, the potential crossover to pet nutrition warrants attention from veterinary professionals and pet owners alike.

Prebiotics are substrates that are selectively utilized by host microorganisms, conferring a health benefit. In companion animals, prebiotics such as fructo-oligosaccharides (FOS) and mannan-oligosaccharides (MOS) have been studied for their effects on gut health, immune function, and nutrient digestibility. However, the discovery of novel prebiotics with enhanced specificity and efficacy could open new avenues for digestive health management in dogs and cats.

This article examines the scientific background of prebiotics in pet nutrition, the role of AI in ingredient discovery, the potential health implications of novel prebiotics, and the veterinary perspective on adopting these ingredients. It also highlights the importance of rigorous safety testing, regulatory oversight, and evidence-based evaluation before new prebiotics can be considered beneficial for companion animals.

Introduction

The gut microbiome is a complex ecosystem of microorganisms that plays a critical role in the health of dogs and cats. Research over the past decade has linked the microbiome to digestion, immune function, nutrient metabolism, and even behavior. As a result, interest in dietary strategies that modulate the microbiome, particularly through prebiotics and probiotics, has grown substantially.

Prebiotics are defined as non-digestible food ingredients that beneficially affect the host by selectively stimulating the growth and/or activity of one or a limited number of bacteria in the colon. In pet food, prebiotics are often added to support digestive health and fecal quality. Common examples include FOS, MOS, inulin, and beet pulp.

Now, AI is emerging as a tool to accelerate the discovery of novel prebiotics. In September 2025, Food Ingredients First reported that Ingredion and Shiru have partnered to develop novel prebiotics using Shiru's AI platform. Although the initial focus appears to be on human nutrition, the same ingredients could eventually enter the pet food market, as many functional ingredients are used across both human and animal applications.

Scientific Background

Prebiotics in Companion Animal Nutrition

The concept of prebiotics is supported by scientific evidence in dogs and cats. A systematic review of studies in dogs found that supplementation with FOS or MOS can increase fecal concentrations of beneficial bacteria such as Bifidobacteria and Lactobacilli while reducing potentially pathogenic bacteria like Clostridium perfringens. In cats, research has shown that prebiotics may improve stool consistency and modulate immune responses.

However, the effects of prebiotics are not always consistent across studies. Factors such as dosage, source, basal diet composition, and individual animal variation can influence outcomes. Moreover, most studies have been short-term, and long-term health benefits remain to be fully established.

How AI Accelerates Ingredient Discovery

AI-driven ingredient discovery involves using machine learning algorithms to analyze vast datasets of molecular structures, biological activities, and chemical interactions. Shiru's platform, for example, uses computational models to predict which molecules are likely to have desirable functional properties, such as prebiotic activity. This approach can screen thousands of candidate compounds in silico, significantly reducing the time and cost compared to traditional screening methods.

For prebiotics, AI can help identify novel carbohydrate structures or plant-derived compounds that may selectively promote beneficial bacteria. It can also predict how these compounds behave during food processing, including their stability and interactions with other ingredients.

Main Analysis

The Ingredion-Shiru partnership represents a strategic move to harness AI for prebiotic innovation. According to the Food Ingredients First article, the collaboration aims to discover novel prebiotics that can be scaled commercially. While specific ingredients were not disclosed, the implications for the broader ingredient market are significant.

For pet nutrition, the potential benefits of AI-discovered prebiotics include:

• Increased specificity: AI could design prebiotics that target particular beneficial bacterial species, potentially offering more precise microbiome modulation than current broad-spectrum prebiotics.
• New sources: AI may identify prebiotic compounds from unconventional or underutilized plant sources, promoting ingredient diversity and sustainability.
• Faster development: Reduced research and development timelines could accelerate the availability of new functional ingredients for pet food.

However, these potential benefits come with challenges. Novel prebiotics must undergo rigorous safety assessments, including toxicity studies, in vitro fermentation models, and randomized controlled trials in dogs and cats. Regulatory bodies such as AAFCO in the United States and FEDIAF in Europe require that ingredients used in pet food be Generally Recognized as Safe (GRAS) or meet other approval criteria. AI discovery is only the first step; clinical validation is essential.

Moreover, the translation of human-oriented ingredients to pet nutrition is not automatic. The digestive physiology of dogs and cats differs from humans, and the optimal prebiotic type and dose for one species may not be appropriate for another. Obligate carnivore cats, in particular, have shorter digestive tracts and different microbial communities than omnivorous dogs, so prebiotic effects may vary significantly.

Health Implications

Digestive Health

If novel prebiotics are proven effective, they could improve digestive health in pets by promoting a balanced gut microbiome. This may lead to better stool quality, reduced flatulence, and lower risk of gastrointestinal disorders. However, over-supplementation of prebiotics can cause bloating, diarrhea, and abdominal discomfort, so careful dosing is required.

Immune Function

A healthy gut microbiome is closely linked to immune function. Prebiotics that enhance beneficial bacteria may support immune responses, potentially reducing susceptibility to infections and allergies. Some evidence in dogs supports a positive effect of prebiotics on vaccine response and fecal IgA levels, but more research is needed.

Weight Management and Metabolic Health

Certain prebiotics have been studied for their effects on satiety and glucose metabolism. In companion animals, obesity is a major health concern, and dietary fibers that promote satiety could aid in weight management. Novel prebiotics with viscous properties might help regulate appetite and nutrient absorption, but clinical evidence in pets is still limited.

Long-Term Wellness and Safety

The long-term safety of novel prebiotics requires careful evaluation. While prebiotics are generally considered safe, unknown compounds may have unintended effects on the microbiome or host physiology. Veterinarians should advise pet owners to choose diets that contain prebiotics with established safety records.

Veterinary Perspective

From a veterinary nutrition standpoint, novel AI-discovered prebiotics are an exciting but unproven area. The veterinary profession traditionally relies on evidence-based medicine, and new ingredients must be thoroughly tested before they can be recommended. Key principles include:

• Nutritional adequacy: Any ingredient added to pet food must not disrupt the overall nutrient balance. AAFCO and FEDIAF nutrient profiles are the baseline.
• Clinical trials: Efficacy and safety should be demonstrated in randomized, controlled trials using the target species. Extrapolation from human data is insufficient.
• Dose response: The ideal dose for pets may differ from humans, and the optimal dose for dogs may differ from cats.
• Monitoring: Veterinarians should monitor patients for adverse effects, especially when novel ingredients are introduced.

Currently, veterinarians are likely to recommend established prebiotics with proven benefits, while remaining open to new products once robust evidence becomes available. Pet owners should be cautious about supplements or foods claiming revolutionary ingredients without published veterinary research.

Future Research

The next 5–10 years will likely see significant advances in AI-assisted ingredient discovery for pet nutrition. Potential developments include:

• Precision nutrition: AI could integrate individual animal data (microbiome, genetics, health status) to recommend personalized prebiotic formulations.
• Microbiome research: Improved metagenomic and metabolomic tools will deepen understanding of the canine and feline gut microbiome, enabling more targeted prebiotic design.
• Safety prediction: Machine learning models may become better at predicting toxicity and adverse interactions before animal trials.
• Sustainability: AI may identify prebiotics from food waste or alternative sources, reducing the environmental footprint of pet food.

Clinical trials will remain the gold standard, but AI can help prioritize candidate ingredients and reduce the number of animals needed for testing.

Conclusion

AI-powered ingredient discovery holds promise for accelerating the development of novel prebiotics, with potential applications in pet nutrition. However, both the veterinary community and pet owners should recognize that AI is a discovery tool, not a guarantee of safety or efficacy. Rigorous scientific evaluation, regulatory oversight, and clinical validation are essential before novel prebiotics can be confidently incorporated into balanced pet diets.

Pet owners should continue to rely on complete and balanced commercial diets that meet recognized nutritional standards. For those considering supplements or functional foods, consultation with a veterinarian is always recommended.

Key Takeaways

• AI is being used to discover novel prebiotics, as exemplified by the Ingredion-Shiru partnership.
• Prebiotics have demonstrated potential for improving digestive health and immune function in dogs and cats, but evidence for individual ingredients varies.
• Novel prebiotics discovered through AI must undergo species-specific safety testing and clinical trials.
• Veterinary guidance and adherence to AAFCO/FEDIAF standards remain essential for ensuring pet health and safety.
• Future research may lead to personalized and more effective prebiotic interventions for companion animals.

Sources

• Food Ingredients First. "AI-powered ingredient discovery gains ground as Ingredion and Shiru target novel prebiotics." Available at: https://www.foodingredientsfirst.com/news/ai-ingredient-discovery-ingredion-shiru-prebiotics.html